| human | Q5 |
| P11496 | CiNii Research ID | 1420845751151381248 |
| P9776 | e-Rad researcher number | 50157252 |
| P7783 | J-GLOBAL ID | 200901089960462598 |
| P271 | NACSIS-CAT author ID | DA06891082 |
| P349 | NDL Authority ID | 00965697 |
| P496 | ORCID iD | 0000-0001-9091-8285 |
| P5029 | Researchmap ID | matsuura_123 |
| P1153 | Scopus author ID | 7202988996 |
| P214 | VIAF ID | 112790541 |
| P27 | country of citizenship | Japan | Q17 |
| P69 | educated at | Hokkaido University | Q1057199 |
| University of Miyazaki | Q1071052 | ||
| ??? | Q11592541 | ||
| P108 | employer | Osaka University | Q651233 |
| P734 | family name | Matsuura | Q16876556 |
| Matsuura | Q16876556 | ||
| Matsuura | Q16876556 | ||
| P735 | given name | Yoshiharu | Q43604406 |
| Yoshiharu | Q43604406 | ||
| P1814 | name in kana | まつうら よしはる | |
| P1559 | name in native language | 松浦善治 | |
| P106 | occupation | veterinarian | Q202883 |
| medical researcher | Q15401884 | ||
| P21 | sex or gender | male | Q6581097 |
| Q112579835 | A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site |
| Q52571268 | A novel occludin-targeting monoclonal antibody prevents hepatitis C virus infection in vitro. |
| Q24307609 | A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replication |
| Q60621618 | ATF6b is a host cellular target of theToxoplasma gondiivirulence factor ROP18 |
| Q35102296 | ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18. |
| Q39609813 | Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64. |
| Q43041645 | Alteration of intrahepatic cytokine expression and AP-1 activation in transgenic mice expressing hepatitis C virus core protein |
| Q38968411 | Alternative endocytosis pathway for productive entry of hepatitis C virus |
| Q34682186 | Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles |
| Q40831561 | An Immune Adherence Assay for Discrimination Between Etiologic Agents of Hemorrhagic Fever with Renal Syndrome |
| Q110185199 | An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies |
| Q43161781 | Animal models for hepatitis C and related liver disease |
| Q109649656 | Anti-CoVid19 plasmid DNA vaccine induces a potent immune response in rodents by Pyro-drive Jet Injector intradermal inoculation |
| Q38879816 | Anti-HCV effect of Lentinula edodes mycelia solid culture extracts and low-molecular-weight lignin |
| Q97652497 | Anti-chikungunya virus monoclonal antibody inhibiting viral fusion and release |
| Q40607475 | Antiapoptotic regulation by hepatitis C virus core protein through up-regulation of inhibitor of caspase-activated DNase |
| Q52729686 | Arabidopsis β1,2-xylosyltransferase: substrate specificity and participation in the plant-specific N-glycosylation pathway. |
| Q29465540 | Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA. |
| Q35826077 | Baculovirus GP64-mediated entry into mammalian cells |
| Q57155195 | Baculovirus as a Tool for Gene Delivery and Gene Therapy |
| Q45722509 | Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice |
| Q39846401 | Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner |
| Q83299561 | Baculovirus transduction of chondrocytes elicits interferon-alpha/beta and suppresses transgene expression |
| Q57064366 | Baculovirus vector for gene delivery and vaccine development |
| Q36740261 | Baculovirus: an insect-derived vector for diverse gene transfer applications |
| Q41829545 | Binding of HSV-1 glycoprotein K (gK) to signal peptide peptidase (SPP) is required for virus infectivity |
| Q27646563 | Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure |
| Q92807007 | Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma |
| Q40536621 | CD14+ monocyte-derived galectin-9 induces natural killer cell cytotoxicity in chronic hepatitis C. |
| Q39366642 | CD44 participates in IP-10 induction in cells in which hepatitis C virus RNA is replicating, through an interaction with Toll-like receptor 2 and hyaluronan |
| Q57069776 | CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C |
| Q27863772 | CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth |
| Q92689397 | CXCR4 regulates Plasmodium development in mouse and human hepatocytes |
| Q39177058 | Ca(2+) /S100 proteins regulate HCV virus NS5A-FKBP8/FKBP38 interaction and HCV virus RNA replication |
| Q38699205 | Cell surface N-glycan alteration in HepAD38 cell lines expressing Hepatitis B virus |
| Q40426320 | Cell-binding properties of the envelope proteins of porcine endogenous retroviruses |
| Q64090834 | Cell-cell fusion induced by reovirus FAST proteins enhances replication and pathogenicity of non-enveloped dsRNA viruses |
| Q39629566 | Chaperonin TRiC/CCT participates in replication of hepatitis C virus genome via interaction with the viral NS5B protein |
| Q40339214 | Characterization of HCV-like particles produced in a human hepatoma cell line by a recombinant baculovirus |
| Q47350163 | Characterization of SPP inhibitors suppressing propagation of HCV and protozoa. |
| Q92218257 | Characterization of human pegivirus infection in liver transplantation recipients |
| Q33719172 | Characterization of miR-122-independent propagation of HCV. |
| Q45871396 | Characterization of rabies virus glycoprotein expressed by recombinant baculovirus |
| Q43046938 | Characterization of recombinant Flaviviridae viruses possessing a small reporter-tag |
| Q27489790 | Cochaperone Activity of Human Butyrate-Induced Transcript 1 Facilitates Hepatitis C Virus Replication through an Hsp90-Dependent Pathway |
| Q40605486 | Comparison of serum sensitivities of pseudotype retroviruses produced from newly established packaging cell lines of human and feline origins |
| Q43289803 | Concanavalin A affinity chromatography for efficient baculovirus purification |
| Q27486112 | Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection |
| Q27477993 | Critical role of PA28 in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis |
| Q38294458 | Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase at a resolution of 1.8 A. |
| Q36640766 | Crystallization and preliminary X-ray diffraction analysis of recombinant hepatitis E virus-like particle. |
| Q42255609 | Detection of hepatitis C virus by single-step hairpin primer RT-PCR. |
| Q40829110 | Determination by Immune Adherence HA of the Antigenic Relationship Between Rattus- and Apodemus-Borne Viruses Causing Hemorrhagic Fever with Renal Syndrome |
| Q35679152 | Development and Applications of VSV Vectors Based on Cell Tropism |
| Q43435379 | Development of HCV vaccine |
| Q90434148 | Development of Stable Rotavirus Reporter Expression Systems |
| Q90114544 | Development of a High-Throughput Serum Neutralization Test Using Recombinant Pestiviruses Possessing a Small Reporter Tag |
| Q40043190 | Development of hepatoma-derived, bidirectional oval-like cells as a model to study host interactions with hepatitis C virus during differentiation |
| Q27860455 | Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses |
| Q64954785 | Discovery of peroxisome proliferator-activated receptor α (PPARα) activators with a ligand-screening system using a human PPARα-expressing cell line. |
| Q27472930 | Diverging Effects of Human Recombinant Anti-Hepatitis C Virus (HCV) Antibody Fragments Derived from a Single Patient on the Infectivity of a Vesicular Stomatitis Virus/HCV Pseudotype |
| Q40349606 | Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein |
| Q79525583 | Dvl regulates endo- and exocytotic processes through binding to synaptotagmin |
| Q39458949 | Dysfunction of autophagy participates in vacuole formation and cell death in cells replicating hepatitis C virus |
| Q90429495 | Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis |
| Q24315791 | E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein |
| Q33799276 | Elimination of hepatitis C virus from hepatocytes by a selective activation of therapeutic molecules |
| Q112582875 | Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2 |
| Q24338491 | Enhanced TLR-mediated NF-IL6 dependent gene expression by Trib1 deficiency |
| Q40352768 | Entirely plasmid-based reverse genetics system for rotaviruses |
| Q43578021 | Entry mechanisms of HCV |
| Q34045644 | Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus |
| Q84315582 | Establishment of a Virulent Full-Length cDNA Clone for Type I Feline Coronavirus Strain C3663 |
| Q39437753 | Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122. |
| Q106623608 | Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction |
| Q39717179 | Establishment of an indicator cell system for hepatitis C virus |
| Q39946471 | Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice |
| Q52099784 | Evaluation of a newly developed immunochromatographic method for detection of norovirus. |
| Q47555431 | Evaluation of viral contamination in a baculovirus expression system |
| Q36919445 | Evaluation systems for anti-HCV drugs |
| Q42987088 | Evidence for a polytopic form of the E1 envelope glycoprotein of Hepatitis C virus |
| Q42981991 | Expression and characterization of glycoprotein gp35 of hepatitis C virus using recombinant vaccinia virus |
| Q36171910 | Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus |
| Q41611375 | Expression of the amino-terminal half of the NS1 region of the hepatitis C virus genome and detection of an antibody to the expressed protein in patients with liver diseases |
| Q43041152 | Expression profiling of liver cell lines expressing entire or parts of hepatitis C virus open reading frame |
| Q40382996 | Extensive Ca2+ leak through K4750Q cardiac ryanodine receptors caused by cytosolic and luminal Ca2+ hypersensitivity |
| Q99247762 | Generation of genetically RGD σ1-modified oncolytic reovirus that enhances JAM-A-independent infection of tumor cells |
| Q41743928 | Hallmarks of hepatitis C virus in equine hepacivirus |
| Q36305699 | Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide |
| Q113276861 | Hepatitis C virus NS5A protein promotes the lysosomal degradation of diacylglycerol O-acyltransferase 1 (DGAT1) via endosomal microautophagy |
| Q24306116 | Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90 |
| Q34542237 | Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice |
| Q42994227 | Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression |
| Q37102724 | Hepatitis C virus core protein: its coordinate roles with PA28gamma in metabolic abnormality and carcinogenicity in the liver |
| Q24310415 | Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines |
| Q40930238 | Hepatitis virus related viruses |
| Q36694117 | Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx |
| Q35362977 | Heterogeneous nuclear ribonucleoprotein A2 participates in the replication of Japanese encephalitis virus through an interaction with viral proteins and RNA. |
| Q93267775 | Host ESCRT factors are recruited during Chikungunya virus infection and are required the intracellular viral replication cycle |
| Q82513645 | Host factors involved in regulation of replication and pathogenesis of hepatitis C virus |
| Q36847659 | Host factors involved in the replication of hepatitis C virus |
| Q37731571 | Host innate immune responses induced by baculovirus in mammals |
| Q33880854 | Host-derived apolipoproteins play comparable roles with viral secretory proteins Erns and NS1 in the infectious particle formation of Flaviviridae |
| Q37252970 | Human Cathelicidin Compensates for the Role of Apolipoproteins in Hepatitis C Virus Infectious Particle Formation |
| Q24338324 | Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B |
| Q24337683 | Human VAP-C negatively regulates hepatitis C virus propagation |
| Q39232046 | Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus |
| Q24305040 | Human butyrate-induced transcript 1 interacts with hepatitis C virus NS5A and regulates viral replication |
| Q98621988 | IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome |
| Q28284657 | IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowth |
| Q98164100 | ISGylation of hepatitis C virus NS5A protein promotes viral RNA replication via the recruitment of cyclophilin A |
| Q101156108 | Identification of GII.14[P7] norovirus and its genomic mutations from a case of long-term infection in a post-symptomatic individual |
| Q37511604 | Identification of basal promoter and enhancer elements in an untranslated region of the TT virus genome |
| Q37123212 | Ifit1 inhibits Japanese encephalitis virus replication through binding to 5' capped 2'-O unmethylated RNA. |
| Q43048126 | Immunization with recombinant Calmette-Guerin bacillus (BCG)-hepatitis C virus (HCV) elicits HCV-specific cytotoxic T lymphocytes in mice |
| Q41955153 | Improved serodiagnosis of non-A, non-B hepatitis by an assay detecting antibody to hepatitis C virus core antigen |
| Q92964685 | In Vivo Dynamics of Reporter Flaviviridae Viruses |
| Q91862894 | In Vivo Live Imaging of Oncolytic Mammalian Orthoreovirus Expressing NanoLuc Luciferase in Tumor Xenograft Mice |
| Q36464489 | In vitro and in vivo gene delivery by recombinant baculoviruses. |
| Q40956888 | Indoleamine-2,3-dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B. |
| Q40746853 | Induction of Bad-mediated apoptosis by Sindbis virus infection: involvement of pro-survival members of the Bcl-2 family |
| Q104486317 | Induction of HOX genes by HCV infection via impairment of histone H2A monoubiquitination |
| Q40687696 | Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus |
| Q57471518 | Induction of selective autophagy in cells replicating hepatitis C virus genome |
| Q40705725 | Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation -- effect of transforming growth factor beta. |
| Q59127567 | Infection with flaviviruses requires BCLXL for cell survival |
| Q39498578 | Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation. |
| Q37547066 | Innate immune response induced by baculovirus attenuates transgene expression in mammalian cells |
| Q37518614 | Integration of the 5' end of the retrotransposon, R2Bm, can be complemented by homologous recombination |
| Q27486780 | Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles |
| Q24292694 | Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity |
| Q82513612 | Interface between viruses and host |
| Q39603646 | Intracellular delivery of serum-derived hepatitis C virus |
| Q24658154 | Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation |
| Q34193354 | Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein |
| Q27490958 | Involvement of Ceramide in the Propagation of Japanese Encephalitis Virus |
| Q28115857 | Involvement of FKBP6 in hepatitis C virus replication |
| Q42999000 | Involvement of PA28gamma in the propagation of hepatitis C virus |
| Q24317879 | Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein |
| Q39600135 | Involvement of cyclophilin B in the replication of Japanese encephalitis virus |
| Q27478049 | Involvement of the PA28 -Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein |
| Q38330661 | Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus |
| Q45856211 | Isolation of Lymphocytic Choriomeningitis Virus from Wild House Mice (Mus musculus) in Osaka Port, Japan |
| Q36506947 | Japanese encephalitis virus core protein inhibits stress granule formation through an interaction with Caprin-1 and facilitates viral propagation |
| Q56897808 | Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling |
| Q41649077 | Kinase-interacting substrate screening is a novel method to identify kinase substrates |
| Q47412814 | Lethal murine infection model for human respiratory disease-associated Pteropine orthoreovirus |
| Q42716737 | Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses |
| Q36010861 | Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus |
| Q41216321 | Long-term viral shedding and viral genome mutation in norovirus infection |
| Q40069598 | MERS coronavirus nsp1 participates in an efficient propagation through a specific interaction with viral RNA. |
| Q35669529 | Mechanisms of hepatitis C virus infection |
| Q40327715 | Mitochondrial damage elicits a TCDD-inducible poly(ADP-ribose) polymerase-mediated antiviral response |
| Q24647301 | Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic targeting of PSD-95 |
| Q37743200 | Molecular determinants for subcellular localization of hepatitis C virus core protein |
| Q90852417 | N-terminal HCV core protein fragment decreases 20S proteasome activity in the presence of PA28γ |
| Q90104795 | Neo-virology: The raison d'etre of viruses |
| Q39643121 | Network based analysis of hepatitis C virus core and NS4B protein interactions |
| Q36255920 | Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver |
| Q97677974 | Norovirus transmission mediated by asymptomatic family members in households |
| Q91887815 | Novel anti-flavivirus drugs targeting the nucleolar distribution of core protein |
| Q54728815 | Novel miRNA biomarkers for genotoxicity screening in mouse. |
| Q33602824 | Novel permissive cell lines for complete propagation of hepatitis C virus |
| Q41748590 | Novel sex-dependent differentially methylated regions are demethylated in adult male mouse livers |
| Q27469457 | Nuclear localization of Japanese encephalitis virus core protein enhances viral replication |
| Q40302317 | Nucleolar protein B23 interacts with Japanese encephalitis virus core protein and participates in viral replication |
| Q59354132 | Oenothein B, dimeric hydrolysable tannin inhibiting HCV invasion from Oenothera erythrosepala |
| Q27477612 | Oligomerization of Hepatitis C Virus Core Protein Is Crucial for Interaction with the Cytoplasmic Domain of E1 Envelope Protein |
| Q43001665 | Pathogenesis of lipid metabolism disorder in hepatitis C: polyunsaturated fatty acids counteract lipid alterations induced by the core protein |
| Q42999290 | Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection |
| Q64134231 | Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA |
| Q104511645 | Ponesimod suppresses hepatitis B virus infection by inhibiting endosome maturation |
| Q112702344 | Preclinical study of a DNA vaccine targeting SARS-CoV-2 |
| Q46047262 | Processing and pathogenicity of HCV core protein |
| Q27481023 | Processing of Capsid Protein by Cathepsin L Plays a Crucial Role in Replication of Japanese Encephalitis Virus in Neural and Macrophage Cells |
| Q39667354 | Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication. |
| Q42980379 | Production and release of infectious hepatitis C virus from human liver cell cultures in the three-dimensional radial-flow bioreactor |
| Q36610885 | Production of hepatitis E virus-like particles presenting multiple foreign epitopes by co-infection of recombinant baculoviruses |
| Q33877391 | Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription |
| Q40282946 | Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b. |
| Q27487945 | Proteasomal Turnover of Hepatitis C Virus Core Protein Is Regulated by Two Distinct Mechanisms: a Ubiquitin-Dependent Mechanism and a Ubiquitin-Independent but PA28 -Dependent Mechanism |
| Q24322067 | Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein |
| Q39339837 | Proteomic analysis of hepatitis C virus (HCV) core protein transfection and host regulator PA28γ knockout in HCV pathogenesis: a network-based study |
| Q40532515 | Pseudotype hepatitis C virus enters immature myeloid dendritic cells through the interaction with lectin |
| Q33190701 | Purification and characterization of a low M(r) GTP-binding protein, ram p25, expressed by baculovirus expression system |
| Q38711204 | Quasispecies of Hepatitis C Virus Participate in Cell-Specific Infectivity |
| Q28213976 | Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170 |
| Q42201561 | Reduced-dose telaprevir-based triple antiviral therapy for recurrent hepatitis C after living donor liver transplantation |
| Q39292478 | Reevaluation of host ranges of feline leukemia virus subgroups |
| Q40041785 | Regulation of Apoptosis during Flavivirus Infection |
| Q122404573 | Repeated Intravaginal Inoculation of Zika Virus Protects Cynomolgus Monkeys from Subcutaneous Superchallenge |
| Q27481021 | Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins |
| Q40088701 | Reverse Genetics System Demonstrates that Rotavirus Nonstructural Protein NSP6 Is Not Essential for Viral Replication in Cell Culture |
| Q35931526 | Reverse Genetics for Fusogenic Bat-Borne Orthoreovirus Associated with Acute Respiratory Tract Infections in Humans: Role of Outer Capsid Protein σC in Viral Replication and Pathogenesis |
| Q46185823 | Rho-kinase contributes to sustained RhoA activation through phosphorylation of p190A RhoGAP. |
| Q92935671 | Rimonabant suppresses RNA transcription of hepatitis B virus by inhibiting hepatocyte nuclear factor 4α |
| Q36973388 | Role of miR-122 and lipid metabolism in HCV infection |
| Q39021540 | Role of mouse and human autophagy proteins in IFN-γ-induced cell-autonomous responses against Toxoplasma gondii |
| Q35423569 | Role of the endoplasmic reticulum-associated degradation (ERAD) pathway in degradation of hepatitis C virus envelope proteins and production of virus particles |
| Q36048951 | Role of zinc-finger anti-viral protein in host defense against Sindbis virus |
| Q38598477 | Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus |
| Q38985597 | Roles of lipoprotein and apolipoprotein in HCV infection |
| Q92163059 | Roles of secretory glycoproteins in particle formation of Flaviviridae viruses |
| Q47552281 | Roles of the 5' untranslated region of non-primate hepacivirus in translation initiation and viral replication |
| Q120816871 | SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression |
| Q120816881 | SARS-CoV-2 infection triggers paracrine senescence and leads to a sustained senescence-associated inflammatory response |
| Q109649929 | SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity |
| Q112694543 | Secretory glycoprotein NS1 plays a crucial role in the particle formation of flaviviruses |
| Q41924282 | Semagacestat Is a Pseudo-Inhibitor of γ-Secretase |
| Q44040688 | Seroepidemiological survey of lymphocytic choriomeningitis virus in wild house mouse(Mus musculus)in Yokohama Port, Japan |
| Q36276237 | Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA. |
| Q24322876 | Signal peptidase complex subunit 1 participates in the assembly of hepatitis C virus through an interaction with E2 and NS2 |
| Q44190163 | Site-directed mutagenesis of His-42, His-188 and Lys-263 of human aldose reductase |
| Q38324768 | Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus |
| Q33967148 | Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study |
| Q59355756 | St6gal1 knockdown alters HBV life cycle in HepAD38 cells |
| Q57064243 | Structural Proteins of HCV and Biological Functions |
| Q42688349 | Structural analysis of vaccinia virus DIs strain: application as a new replication-deficient viral vector |
| Q37858159 | Structure of hepatitis E viral particle |
| Q24675969 | Sumoylation is involved in beta-catenin-dependent activation of Tcf-4 |
| Q40112750 | Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9. |
| Q112726126 | Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy |
| Q36871730 | TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis |
| Q37362077 | Tacrolimus ameliorates metabolic disturbance and oxidative stress caused by hepatitis C virus core protein: analysis using mouse model and cultured cells |
| Q43167093 | Tellimagrandin I, HCV invasion inhibitor from Rosae Rugosae Flos |
| Q108396537 | The N-terminal domain of spike glycoprotein mediates SARS-CoV-2 infection by associating with L-SIGN and DC-SIGN |
| Q41688191 | The RAB2B-GARIL5 Complex Promotes Cytosolic DNA-Induced Innate Immune Responses |
| Q30519429 | The inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migration |
| Q112697454 | The nonstructural p17 protein of a fusogenic bat-borne reovirus regulates viral replication in virus species- and host-specific manners |
| Q24306840 | The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA |
| Q35225243 | Tightly regulated expression of Autographa californica multicapsid nucleopolyhedrovirus immediate early genes emerges from their interactions and possible collective behaviors |
| Q42981626 | Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection |
| Q40110758 | Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication |
| Q90969665 | USP15 Participates in Hepatitis C Virus Propagation through Regulation of Viral RNA Translation and Lipid Droplet Formation |
| Q40185810 | Unconjugated interferon-stimulated gene 15 specifically interacts with the hepatitis C virus NS5A protein via domain I. |
| Q39150728 | Understanding the biological context of NS5A-host interactions in HCV infection: a network-based approach |
| Q39504086 | Unique Requirement for ESCRT Factors in Flavivirus Particle Formation on the Endoplasmic Reticulum |
| Q120816862 | Upregulation of Robo4 expression by SMAD signaling suppresses vascular permeability and mortality in endotoxemia and COVID-19 models |
| Q42324512 | Upregulation of nuclear PA28γ expression in cirrhosis and hepatocellular carcinoma |
| Q30910565 | Usage of myeloma and panning in retrovirus-mediated expression cloning |
| Q43042479 | Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection |
| Q42999224 | Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C. |
| Q96647158 | Various miRNAs compensate the role of miR-122 on HCV replication |
| Q57064382 | Virus-Cell Interaction of HCV |
| Q43037214 | Will there be an HCV meeting in 2020? Summary of the 17th international meeting on hepatitis C virus and related viruses |
| Q37049502 | Zinc-finger antiviral protein mediates retinoic acid inducible gene I-like receptor-independent antiviral response to murine leukemia virus |
| Q79894986 | [Baculovirus vector--gene transfer into mammalian cells] |
| Q80548588 | [Candidate molecules for HCV receptor] |
| Q81155243 | [Entry mechanisms of hepatitis C virus] |
| Q74778435 | [Infection mechanisms of hepatitis C virus] |
| Q50568945 | [Pathogenesis of hepatitis C virus]. |
| Q85559084 | [miR-122 participates in the cell tropism of hepatitis C virus] |
| 松浦善治 | wikipedia |
Search more.